Krensavage Asset Management, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001609251
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2024 · 13 positions · Total reported value $178.46M · Top-10 concentration 98.6% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 20.0% · 0 new · 2 cut · 2 exited
Active Share (vs S&P 500): 99.6% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +6.8% · vs SPY -8.0% · Prev Value $255.70M — last quarter positions weighted by this quarter price moves · ranking
In its Q3 2024 13F filing, Krensavage Asset Management, LLC disclosed 13 equity positions with a combined reported value of $178.46M. The filing implies a focused portfolio: its ten largest positions account for 98.6% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2024 were UTHR ($35.95M), EXEL ($33.26M), CAH ($23.24M). By sector, the heaviest allocations are Health Care 99.9%, Other 0.1%. Versus the prior quarter, allocation shifted toward Health Care (+12.8pp) and away from Other (-12.8pp).
Versus the prior quarter, Krensavage Asset Management, LLC opened 0 new positions, trimmed 2 and fully exited 2, a turnover rate of 20.0% of positions. The portfolio's overlap with the prior quarter was 86% of names.
The largest new positions opened in Q3 2024 were INDV ($6.84M).
Of the 2 positions fully exited versus the prior quarter, the largest were TARO ($27.95M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2024)
- INDV INDIVIOR PHARMACEUTICALS INC · $6.84M
Fully Exited (vs previous quarter)
- TARO TARO PHARMACEUTICAL INDS LTD · prev qtr: $27.95M
Insider Transactions (Form 4)
Latest Krensavage Asset Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Krensavage Asset Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 18 positions worth $263.22M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-78631 (status: Approved), registered 2013-10-04
- Regulatory AUM (Form ADV): $300.23M as of 2026-03-25
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
Portfolio Structure
- 18 positions · $263.22M reported value (Q2 2026)
- Top 10 holdings = 89.4% of reported value
- Largest position: ENTA (ENANTA PHARMACEUTICALS INC COM) at 15.9%
- Average position size: $14.62M
Sector Tilt
- Health Care 100.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 4 added, 2 reduced, 2 exited
- 12 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
100.33K | $35.95M | 20.15% | Reduce | |
| 2 |
|
1.28M | $33.26M | 18.64% | Reduce | |
| 3 |
|
210.26K | $23.24M | 13.02% | Reduce | |
| 4 |
|
113.50K | $22.00M | 12.33% | Reduce | |
| 5 |
|
1.50M | $15.52M | 8.70% | Add | |
| 6 |
|
110.26K | $12.28M | 6.88% | Add | |
| 7 |
|
93.58K | $11.12M | 6.23% | Reduce | |
| 8 |
|
150.21K | $8.66M | 4.85% | Reduce | |
| 9 |
|
251.50K | $7.04M | 3.94% | Reduce | |
| 10 |
|
701.87K | $6.84M | 3.83% | New | |
| 11 |
|
414.68K | $1.95M | 1.09% | Reduce | |
| 12 |
|
353 | $371.00K | 0.21% | Reduce | |
| 13 |
|
75.87K | $237.00K | 0.13% | Add | |
FAQ
What did Krensavage Asset Management, LLC buy in 2024-Q3?
In its 2024-Q3 13F filing, Krensavage Asset Management, LLC reported 13 equity positions worth $178.46M in aggregate; its largest disclosed positions were UTHR ($35.95M), EXEL ($33.26M), CAH ($23.24M).
How large is Krensavage Asset Management, LLC's portfolio?
Krensavage Asset Management, LLC reported $178.46M of long equity holdings across 13 positions as of 2024-Q3. Top-10 holdings account for 98.6% of reported value.
What is Krensavage Asset Management, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.